Stock Track | MiMedx Group Soars 7.79% After-Hours on Strong Q3 Earnings, Beating Estimates

Stock Track10-30

MiMedx Group, Inc. (NASDAQ: MDXG) saw its stock price surge 7.79% in after-hours trading on Wednesday, following the release of its impressive third-quarter 2025 financial results that significantly exceeded analyst expectations.

The company reported record quarterly net sales of $113.7 million, representing a substantial 35.3% increase compared to the same period in 2024. This figure impressively surpassed the analyst consensus estimate of $94.1 million by 20.80%. MiMedx's strong performance was driven by robust growth across its product lines, with wound product sales up 40% and surgical product sales increasing by 26% year-over-year.

Profitability also saw a marked improvement, with net income from continuing operations more than doubling to $16.7 million. Adjusted earnings per share came in at $0.15, handily beating the analyst estimate of $0.07. The company's gross profit rose by 38.2% to $95.0 million, while adjusted EBITDA reached $34.95 million. Additionally, MiMedx raised its full-year 2025 outlook, now expecting net sales growth in the mid-to-high teens as a percentage compared to 2024, with adjusted EBITDA margin projected to be at least in the mid-20% range. This strong performance and positive forward guidance likely contributed to the significant after-hours stock price increase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1195912218?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 04:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195912218","market":"sg","top_or_hot":-1,"title":"Stock Track | MiMedx Group Soars 7.79% After-Hours on Strong Q3 Earnings, Beating Estimates","media":"Stock Track","content":"<p>MiMedx Group, Inc. (NASDAQ: MDXG) saw its stock price surge 7.79% in after-hours trading on Wednesday, following the release of its impressive third-quarter 2025 financial results that significantly exceeded analyst expectations.</p>\n\n<p>The company reported record quarterly net sales of $113.7 million, representing a substantial 35.3% increase compared to the same period in 2024. This figure impressively surpassed the analyst consensus estimate of $94.1 million by 20.80%. MiMedx's strong performance was driven by robust growth across its product lines, with wound product sales up 40% and surgical product sales increasing by 26% year-over-year.</p>\n\n<p>Profitability also saw a marked improvement, with net income from continuing operations more than doubling to $16.7 million. Adjusted earnings per share came in at $0.15, handily beating the analyst estimate of $0.07. The company's gross profit rose by 38.2% to $95.0 million, while adjusted EBITDA reached $34.95 million. Additionally, MiMedx raised its full-year 2025 outlook, now expecting net sales growth in the mid-to-high teens as a percentage compared to 2024, with adjusted EBITDA margin projected to be at least in the mid-20% range. This strong performance and positive forward guidance likely contributed to the significant after-hours stock price increase.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | MiMedx Group Soars 7.79% After-Hours on Strong Q3 Earnings, Beating Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | MiMedx Group Soars 7.79% After-Hours on Strong Q3 Earnings, Beating Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-30 04:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MiMedx Group, Inc. (NASDAQ: MDXG) saw its stock price surge 7.79% in after-hours trading on Wednesday, following the release of its impressive third-quarter 2025 financial results that significantly exceeded analyst expectations.</p>\n\n<p>The company reported record quarterly net sales of $113.7 million, representing a substantial 35.3% increase compared to the same period in 2024. This figure impressively surpassed the analyst consensus estimate of $94.1 million by 20.80%. MiMedx's strong performance was driven by robust growth across its product lines, with wound product sales up 40% and surgical product sales increasing by 26% year-over-year.</p>\n\n<p>Profitability also saw a marked improvement, with net income from continuing operations more than doubling to $16.7 million. Adjusted earnings per share came in at $0.15, handily beating the analyst estimate of $0.07. The company's gross profit rose by 38.2% to $95.0 million, while adjusted EBITDA reached $34.95 million. Additionally, MiMedx raised its full-year 2025 outlook, now expecting net sales growth in the mid-to-high teens as a percentage compared to 2024, with adjusted EBITDA margin projected to be at least in the mid-20% range. This strong performance and positive forward guidance likely contributed to the significant after-hours stock price increase.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDXG","symbol_name":"MiMedx Group, Inc.","start_time":0,"source_url":"","article_id":"1195912218","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195912218","pubTimestamp":1761771518,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"MiMedx Group, Inc. (NASDAQ: MDXG) saw its stock price surge 7.79% in after-hours trading on Wednesday, following the release of its impressive third-quarter 2025 financial results that significantly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDXG":"MiMedx Group, Inc."},"translate_title":"个股追踪|MiMedx Group盘后飙升7.79%，第三季度盈利强劲，超出预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDXG":1},"content_text":"MiMedx Group, Inc. (NASDAQ: MDXG) saw its stock price surge 7.79% in after-hours trading on Wednesday, following the release of its impressive third-quarter 2025 financial results that significantly exceeded analyst expectations.\nThe company reported record quarterly net sales of $113.7 million, representing a substantial 35.3% increase compared to the same period in 2024. This figure impressively surpassed the analyst consensus estimate of $94.1 million by 20.80%. MiMedx's strong performance was driven by robust growth across its product lines, with wound product sales up 40% and surgical product sales increasing by 26% year-over-year.\nProfitability also saw a marked improvement, with net income from continuing operations more than doubling to $16.7 million. Adjusted earnings per share came in at $0.15, handily beating the analyst estimate of $0.07. The company's gross profit rose by 38.2% to $95.0 million, while adjusted EBITDA reached $34.95 million. Additionally, MiMedx raised its full-year 2025 outlook, now expecting net sales growth in the mid-to-high teens as a percentage compared to 2024, with adjusted EBITDA margin projected to be at least in the mid-20% range. This strong performance and positive forward guidance likely contributed to the significant after-hours stock price increase.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1195912218","isCrawlerRequest":true}